Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304092 | 0.73 | ERN1 (0.41) | PRKDCERN1LMNA | |
| SCHEMBL3185596 | 0.72 | ERN1 (0.50) | PRKDCERN1LMNA | |
| SCHEMBL31367053 | 0.70 | ALDH1A1 (0.42) | ERN1 | |
| SCHEMBL5426089 | 0.69 | PGR (0.31) | PRKDCERN1 | |
| SCHEMBL23658839 | 0.69 | ERN1 (0.54) | PRKDCERN1LMNA | |
| SCHEMBL1726007 | 0.69 | ERN1 (0.37) | PRKDCERN1LMNA | |
| SCHEMBL28302905 | 0.69 | GAA (0.50) | PRKDCERN1LMNA | |
| SCHEMBL19616991 | 0.69 | ERN1 (0.42) | PRKDCERN1LMNA | |
| SCHEMBL31353147 | 0.68 | LMNA (0.41) | PRKDCERN1LMNA | |
| SCHEMBL3971701 | 0.67 | ERN1 (0.37) | ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366629-A1 | Porphyrin Complexes as Antidotes for Carbon Monoxide Exposure and Methods of Use for Same | UNIV CALIFORNIA (US) | 2024-11-07 | — | — | US | disclosed |
| EP-4395773-A1 | PORPHYRIN COMPLEXES AS ANTIDOTES FOR CARBON MONOXIDE EXPOSURE AND METHODS OF USE FOR SAME | The Regents of the University of California (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2023034447-A9 | PORPHYRIN COMPLEXES AS ANTIDOTES FOR CARBON MONOXIDE EXPOSURE AND METHODS OF USE FOR SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-04-20 | — | — | WO | disclosed |
| WO-2023034447-A1 | PORPHYRIN COMPLEXES AS ANTIDOTES FOR CARBON MONOXIDE EXPOSURE AND METHODS OF USE FOR SAME | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-09 | — | — | WO | disclosed |
| EP-3071631-B1 | AMINE FUNCTIONALIZED POROUS NETWORK | UNIV KING ABDULLAH SCI & TECH (SA) | 2020-09-02 | — | — | EP | disclosed |
| US-9663627-B2 | Amine functionalized porous network | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2017-05-30 | — | — | US | disclosed |
| EP-3071631-A1 | AMINE FUNCTIONALIZED POROUS NETWORK | King Abdullah University Of Science And Technology (SA) | 2016-09-28 | — | — | EP | disclosed |
| CN-105916912-A | Amine functionalized porous network | 阿卜杜拉国王科技大学 | 2016-08-31 | — | — | CN | disclosed |
| US-20150148439-A1 | AMINE FUNCTIONALIZED POROUS NETWORK | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2015-05-28 | — | — | US | disclosed |
| WO-2015077444-A1 | AMINE FUNCTIONALIZED POROUS NETWORK | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2015-05-28 | — | — | WO | disclosed |
| US-7417142-B2 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) | 2008-08-26 | — | — | US | disclosed |
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2006-02-09 | — | — | US | disclosed |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060030718-A1 | Cobalt-based catalysts for the cyclization of alkenes | PPOX, HCCS, ICOSLG | PRKDC 3897/4885ERN1 4454/4885LMNA 1845/4885 |
| US-20240366629-A1 | Porphyrin Complexes as Antidotes for Carbon Monoxide Exposure and Methods of Use for Same | MB, HMBS, HMOX2 | PRKDC 3090/4885ERN1 4460/4885LMNA 1804/4885 |
| US-20050124596-A1 | Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same | PPOX, PPIF, HMBS | PRKDC 1489/4885ERN1 3635/4885LMNA 4475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.